Page last updated: 2024-08-16

rivastigmine and Acute Brain Injuries

rivastigmine has been researched along with Acute Brain Injuries in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (85.71)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, N; Dougall, D; Poole, N1
Borovikova, VN; Driagina, NV; Kondrat'ev, SA; Kondrat'eva, EA; Voronenko, VA1
Arciniegas, DB; Gunay, I; Harvey, PD; Katz, DI; Koumaras, B; Meng, X; Potkin, SG; Reyes, PF; Silver, JM1
Tenovuo, O1
Arciniegas, D; Chen, M; Gunay, I; Harvey, PD; Katz, DI; Koumaras, B; Mirski, D; Potkin, SG; Reyes, P; Silver, JM; Warden, D1
Hauser, WA; Noble, JM1
Blount, PJ; McDeavitt, JT; Nguyen, CD1

Reviews

3 review(s) available for rivastigmine and Acute Brain Injuries

ArticleYear
Pharmacotherapy for chronic cognitive impairment in traumatic brain injury.
    The Cochrane database of systematic reviews, 2015, Dec-01, Issue:12

    Topics: Adolescent; Adult; Aged; Atomoxetine Hydrochloride; Benzhydryl Compounds; Brain Injuries; Chronic Disease; Cognition; Cognition Disorders; Humans; Middle Aged; Modafinil; Nootropic Agents; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine

2015
[The role of rivastigmine (exelon) in the treatment of consequences of cranial-brain trauma].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:1

    Topics: Brain Injuries; Cognition; Cognition Disorders; Humans; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Treatment Outcome

2009
Clinical use of cholinomimetic agents: a review.
    The Journal of head trauma rehabilitation, 2002, Volume: 17, Issue:4

    Topics: Administration, Oral; Adult; Aged; Alzheimer Disease; Brain Injuries; Carbamates; Clinical Trials as Topic; Cytidine Diphosphate Choline; Donepezil; Female; Follow-Up Studies; Humans; Indans; Injections, Intravenous; Injury Severity Score; Male; Middle Aged; Parasympathomimetics; Phenylcarbamates; Physostigmine; Piperidines; Rivastigmine; Severity of Illness Index; Tacrine; Treatment Outcome

2002

Trials

3 trial(s) available for rivastigmine and Acute Brain Injuries

ArticleYear
Long-term effects of rivastigmine capsules in patients with traumatic brain injury.
    Brain injury, 2009, Volume: 23, Issue:2

    Topics: Adult; Brain Injuries; Capsules; Cognition Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Rivastigmine; Time; Treatment Outcome

2009
Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients.
    Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1

    Topics: Adolescent; Adult; Aged; Brain Damage, Chronic; Brain Injuries; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Female; Galantamine; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Psychomotor Performance; Rivastigmine; Treatment Outcome

2005
Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
    Neurology, 2006, Sep-12, Volume: 67, Issue:5

    Topics: Adolescent; Adult; Antiemetics; Benzamides; Brain Injuries; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome; Vomiting

2006

Other Studies

1 other study(ies) available for rivastigmine and Acute Brain Injuries

ArticleYear
Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
    Neurology, 2007, May-15, Volume: 68, Issue:20

    Topics: Brain Injuries; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Humans; Memory Disorders; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Research Design; Rivastigmine; Treatment Outcome

2007